biotech
biotech Articles
Atara Biotherapeutics shares surged on Friday after the firm announced that it received clearance from the FDA to initiate two Phase 3 clinical studies.
Published:
Last Updated:
Menlo Therapeutics, a late-stage biopharmaceutical company, has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech stocks increased.
Published:
Last Updated:
These two biotech and two tech stocks not only have big upside potential, but they are priced right for investors looking for good entry points.
Published:
Last Updated:
Mallinckrodt has seen its shares rise on news that it was acquiring Sucampo Pharmaceuticals for roughly $840 million.
Published:
Last Updated:
Celgene saw its shares take a step back on Friday after the firm announced results from a late-stage clinical study of patients with follicular lymphoma.
Published:
Last Updated:
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
Published:
Exelixis saw its shares make a handy gain on Wednesday after the company received the nod from the FDA for Cabometyx tablets.
Published:
Last Updated:
Bluebird Bio saw its shares dip on Wednesday after the firm announced the pricing of a secondary offering of more than 3 million shares.
Published:
Last Updated:
Cellectis saw its shares make a handy gain early on Wednesday after the firm announced preliminary data from its two Phase 1 studies in conjunction with Pfizer.
Published:
Last Updated:
Proteostasis Therapeutics shares absolutely exploded in Tuesday’s session, more than doubling after the firm reported positive study results.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a generic version of the pill?
Published:
Last Updated:
Blueprint Medicines watched its shares make a solid gain on Monday morning after the firm announced results for its ongoing early-stage trial for advanced systemic mastocytosis.
Published:
Last Updated: